Arm's IPO prospectus put a number on its China dependence

The signal

In venture and public-market terms, a single large listing is often read as reopening a market that had been closed to new issuers. Arm Holdings' initial Form F-1, filed with the SEC on 21 August 2023, states the chip-design licensor's total revenue for the fiscal year ended 31 March 2023 was $2,679 million, relatively flat against $2,703 million the year before. The company's final prospectus, filed the day after pricing, states the initial public offering priced at $51.00 per American Depositary Share on 13 September 2023, with 95,500,000 ADSs sold for gross proceeds of $4,870,500,000, listing on the Nasdaq Global Select Market under the ticker ARM.

The evidence

The F-1 discloses a structural feature of Arm's business that a headline revenue figure does not convey: Arm China is described as an entity that operates independently of Arm and is Arm's single largest customer, in which a SoftBank-controlled entity holds approximately 48% while Arm itself holds a 10% non-voting interest. The filing states plainly that Arm depends on its commercial relationship with Arm China to access the Chinese market, and warns that deterioration of that relationship could materially and adversely affect its ability to compete there. Reading the F-1 and the final prospectus together separates two different facts: the F-1 documents the underlying licensing business and its concentration risk months before pricing, while the 424B4 documents only the completed transaction's price and size. A single IPO's pricing says something about demand for one company's shares on one day; it does not by itself describe the state of the broader IPO market.

Timeframe and confidence

The revenue figure covers the fiscal year ended 31 March 2023, disclosed in a filing dated 21 August 2023; the pricing and proceeds figures are dated to the transaction itself on 13 September 2023. Confidence in both sets of figures is high, since they come from SEC-filed registration documents rather than press estimates. This is an editorial reading: that one well-covered IPO priced successfully does not establish that the broader market for new listings had reopened, since a single issuer's structural characteristics, here a semiconductor licensor with a captive Chinese customer structure, are not representative of issuers generally.

What would change the reading

A subsequent run of unrelated companies successfully pricing IPOs at or above their expected range in the following two quarters would support reading Arm's listing as reflecting a genuinely reopened market rather than a one-off. A run of withdrawn or downsized offerings following it would weaken that reading.

• Did IPO volume and pricing outcomes for other companies improve in the two quarters after September 2023?
• How did Arm's revenue and its dependence on the Arm China relationship change in the fiscal years after listing?
• What would the FY2023 revenue figure look like restated to separate licensing fees from royalty revenue, which the F-1 does not break out?

The filings establish Arm's own revenue, its customer concentration, and its IPO's price and size; they do not, on their own, establish that one listing reopened a market for others.

Source trail

1. Arm Holdings plc Form F-1 (initial registration statement)www.sec.gov · Source publication: 2023-08-21 · Retrieved 2026-09-16

   States fiscal-year-2023 (ended 31 March 2023) total revenue of $2,679 million, and discloses Arm's dependence on the Arm China joint venture, in which Arm holds a non-voting 10% interest, to access the Chinese market.

2. Arm Holdings plc Prospectus (Form 424B4)www.sec.gov · Source publication: 2023-09-14 · Retrieved 2026-09-16

   States the IPO priced at $51.00 per American Depositary Share, with 95,500,000 ADSs sold for gross proceeds of $4,870,500,000, and confirms Nasdaq listing under the ticker ARM.

Read across the evidence

• The CHIPS Act put $50 billion behind US chip plants
• Chip sales hit a record $555.9 billion in a shortage year
• A venture capital monitor recorded a second down year in 2023

Markets & measurement · All 100 historical records